To assess whether overexpressing Pparα in Usp25−/− mice could mitigate NAFLD in vivo, we administered an adeno-associated virus carrying Pparα into the tail vein to increase hepatic Pparα expression in Usp25−/− mice. This evidence concerns the gene USP25 and metabolic dysfunction-associated steatotic liver disease.